Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment

Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment

The application of cannabis products in oncology receives interest, especially from patients. Despite the plethora of research data available, the added value in curative or palliative cancer care and the possible risks involved are insufficiently proven and therefore a matter of debate. We aim to g...

Full description

Bibliographic Details
Main Authors: Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, Donald A. P. Brugman, Ulrike F. van Ark, Arwin S. Ramcharan, Paul W. Lebbink, Frederik J. H. Hoogwater, Daan G. Knapen, Derk Jan A. de Groot, Maarten W. Nijkamp
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Cancers
Subjects:
cancer treatment
cannabidiol (CBD)
cannabinoids
cannabis products
delta-9-tetrahydrocannabinol (THC)
drug interactions
Online Access:https://www.mdpi.com/2072-6694/15/7/2119

Internet

https://www.mdpi.com/2072-6694/15/7/2119

Similar Items